Synthesis and in Vitro Biological Evaluation of Carbonyl Group-Containing Analogues for σ1 Receptors

被引:15
作者
Wang, Wei [1 ]
Cui, Jinquan [1 ]
Lu, Xiaoxia [1 ]
Padakanti, Prashanth K. [1 ]
Xu, Jinbin [1 ]
Parsons, Stanley M. [2 ,3 ]
Luedtke, Robert R. [4 ]
Rath, Nigam P. [5 ,6 ]
Tu, Zhude [1 ]
机构
[1] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA
[2] Univ Calif Santa Barbara, Dept Chem, Santa Barbara, CA 93106 USA
[3] Univ Calif Santa Barbara, Grad Program Biochem & Mol Biol, Santa Barbara, CA 93106 USA
[4] Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA
[5] Univ Missouri, Dept Chem & Biochem, St Louis, MO 63121 USA
[6] Univ Missouri, Ctr Neurosci, St Louis, MO 63121 USA
基金
美国国家卫生研究院;
关键词
POSITRON-EMISSION-TOMOGRAPHY; STRUCTURE-AFFINITY; VIVO EVALUATION; BINDING-SITE; LIGANDS; CELLS; RADIOTRACER; EXPRESSION; CANCER; PHARMACOLOGY;
D O I
10.1021/jm200203f
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
To identify the ligands for sigma(1) receptors that are potent and selective, analogues of prezamicol and trozamicol scaffolds of carbonyl-containing vesicular acetylcholine transporter (VAChT) inhibitors were explored. Of the 23 analogues synthesized and tested, 5 displayed very high affinity for sigma(1)(K-i = 0.48-4.05 nM) and high selectivity for sigma(1) relative to sigma(2) receptors (sigma(1)/sigma(2) selectivity of >749-fold). Four of the five compounds (14a, 14b, 14c, and 14e) showed very low affinity for VAChT (K-i > 290 nM), and the fifth compound (14g) showed moderate affinity for VAChT (K-i = 44.2 nM). The compound [1'-(4-fluorobenzy1)-3'-hydroxy[1,4']bipiperidinyl-4-yl]-(4-fluorophenyl)methanone (14a) displayed very high affinity and selectivity for sigma(1) receptor (K-i = 0.48 nM, sigma(1)/sigma(2) > 3600). All four of these most promising compounds (14a, 14b, 14c, and 14e) can be radiosynthesized with fluorine-18 or carbon-11, which will allow further evaluation of their properties as PET probes for imaging sigma(1) receptor in vivo.
引用
收藏
页码:5362 / 5372
页数:11
相关论文
共 51 条
  • [1] Abate Carmen, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P246
  • [2] Anti-amnesic properties of (±)-PPCC, a novel sigma receptor ligand, on cognitive dysfunction induced by selective cholinergic lesion in rats
    Antonini, Vuokko
    Prezzavento, Orazio
    Coradazzi, Marino
    Marrazzo, Agostino
    Ronsisvalle, Simone
    Arena, Emanuela
    Leanza, Giampiero
    [J]. JOURNAL OF NEUROCHEMISTRY, 2009, 109 (03) : 744 - 754
  • [3] Spreading depression: from serendipity to targeted therapy in migraine prophylaxis
    Ayata, C.
    [J]. CEPHALALGIA, 2009, 29 (10) : 1095 - 1114
  • [4] Sigma receptors and cancer: Possible involvement of ion channels
    Aydar, E
    Palmer, CP
    Djamgoz, MBA
    [J]. CANCER RESEARCH, 2004, 64 (15) : 5029 - 5035
  • [5] The expression and functional characterization of sigma (σ) 1 receptors in breast cancer cell lines
    Aydar, Ebru
    Onganer, Pinar
    Perrett, Rebecca
    Djamgoz, Mustafa B.
    Palmer, Christopher P.
    [J]. CANCER LETTERS, 2006, 242 (02) : 245 - 257
  • [6] Targeting sigma-1 receptor with fluvoxamine ameliorates pressure-overload-induced hypertrophy and dysfunctions
    Bhuiyan, Md. Shenuarin
    Tagashira, Hideaki
    Shioda, Norifumi
    Fukunaga, Kohji
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (10) : 1009 - 1022
  • [7] Alzheimer's disease
    Scheltens, Philip
    De Strooper, Bart
    Kivipelto, Miia
    Holstege, Henne
    Chetelat, Gael
    Teunissen, Charlotte E.
    Cummings, Jeffrey
    van der Flier, Wiesje M.
    [J]. LANCET, 2021, 397 (10284) : 1577 - 1590
  • [8] Bourrie Bernard, 2004, Curr Opin Investig Drugs, V5, P1158
  • [9] Bowen W D, 2000, Pharm Acta Helv, V74, P211
  • [10] SIGMA-BINDING SITE LIGANDS INHIBIT CELL-PROLIFERATION IN MAMMARY AND COLON-CARCINOMA CELL-LINES AND MELANOMA-CELLS IN CULTURE
    BRENT, PJ
    PANG, GT
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 278 (02) : 151 - 160